VEGFA and glaucoma: Subgroup analysis based on follow-up time revealed that the use of anti-glaucoma medications was significantly lower with the combination of anti-VEGF drugs and AGVI than with AGVI alone at both 1 month and 3 months post-operation ([WMD = −0.45, 95% CI (−0.67, −0.22), p < 0.001] and [WMD = −0.50, 95% CI (−0.66, −0.34), p < 0.001] respectively) (Figure 7).